1. 23680-84-4
2. 2-chloro-6,7-dimethoxyquinazolin-4-amine
3. 2-chloro-4-amino-6,7-dimethoxyquinazoline
4. 2-chloro-6,7-dimethoxy-4-quinazolinamine
5. 4-quinazolinamine, 2-chloro-6,7-dimethoxy-
6. 2-chloro-4-amino-6,7-dimethoxy Quinazoline
7. 2-chloro-4-amino-6,7-dimethoxy-quinazoline
8. Mfcd00051734
9. 2680-84-4
10. Fg7z4t71y4
11. 2-chloro-6,7-dimethoxy-4-aminoquinazoline
12. 2-chloro-6,7-dimethoxyquinazolin-4-ylamine
13. 4-amino-2-chloro-6,7-dimethoxy Quinazoline
14. Sr-01000197509
15. Quinazolinamine
16. Unii-fg7z4t71y4
17. Prazosin Impurity A
18. Einecs 245-821-7
19. Doxazosin Impurity F
20. Terazosin Impurity A
21. Ec 245-821-7
22. Dsstox_cid_31483
23. Dsstox_rid_97368
24. Dsstox_gsid_57694
25. Bidd:gt0452
26. Schembl611438
27. 10-propoxy-decanoicacid
28. Chembl3561187
29. Dtxsid3057694
30. (e/z)-trelnarizine Dihydrochloride
31. Albb-005949
32. Bcp28790
33. Zinc2028665
34. Tox21_113801
35. Stk503641
36. Akos000264944
37. Ac-5334
38. Ps-3289
39. 4amino-2-chloro6,7-dimethoxyquinazoline
40. Ncgc00253677-01
41. 4-amino-2chloro-6,7-dimethoxyquinazoline
42. Sy008892
43. 4-amino-2-chloro-6,7-dimethoxyquinazolin
44. 2-chloro-6,7-dimethoxy Quinazolin-4-amine
45. 2-chloro-6,7-dimethoxyquinazoline-4-amine
46. 4-amino-2-chloro-6,7-dimethoxy-quinzoline
47. 4-amino-2-chloro-6,7-dimethoxyquinozoline
48. 4-amino-2chloro-6,7-dimethoxy Quinazoline
49. Cas-23680-84-4
50. Db-046221
51. 2-chloro-4-amino-6,7-dimethoxyquin-azoline
52. 2-chloro-6,7-dimethoxy-4-quinazolinamine #
53. 4-amino-2-chloro-6,7-bismethoxyquinazoline
54. 4-amino-2-chloro-6,7-dimethoxy-quinazoline
55. Am20030412
56. Bb 0257419
57. Cs-0127991
58. Ft-0620860
59. Doxazosin Related Compound C [usp-rs]
60. En300-66004
61. 80c844
62. 4-amino-2-chloro-6,7-dimethoxyquinazoline, 95%
63. Ae-848/31926053
64. Doxazosin Mesilate Impurity F [ep Impurity]
65. Doxazosin Related Compound C [usp Impurity]
66. Sr-01000197509-1
67. Sr-01000197509-2
68. W-107385
69. Prazosin Hydrochloride Impurity A [ep Impurity]
70. Q27277971
71. Quinazoline, 4-amino-2-chloro-6,7-dimethoxy-
72. Alfuzosin Hydrochloride Impurity B [ep Impurity]
73. Z1741965684
74. Doxazosin Impurity F, European Pharmacopoeia (ep) Reference Standard
75. Terazosin Hydrochloride Dihydrate Impurity A [ep Impurity]
76. Terazosin Impurity A, European Pharmacopoeia (ep) Reference Standard
77. 4-amino-2-chloro-6,7-dimethoxyquinazoline, Puriss., >=99.0% (hplc)
78. Doxazosin Related Compound C, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 239.66 g/mol |
|---|---|
| Molecular Formula | C10H10ClN3O2 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 239.0461543 g/mol |
| Monoisotopic Mass | 239.0461543 g/mol |
| Topological Polar Surface Area | 70.3 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 244 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
END USE APIs
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Synthokem Labs specializes in producing APIs and intermediates for the global pharma industry.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
RELATED INTERMEDIATES
MARKET PLACE
